Analyst ratings
10 analysts have weighed in: a Strong Buy consensus: 8 buy calls against 0 sell, with an average 12-month price target of $15.45.
Altimmune 路 NASDAQ: ALT 路 Biotechnology
Over the past week, Altimmune (ALT) drew about 21 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 45% bullish but is sharply divided: News runs 60% bullish while X sits at just 36%. Wall Street is more constructive, with 8 of 10 analysts rating ALT a buy.
There is little buzz around ALT this week and some agreement on direction, which is why it reads as a Sell.
Wall Street’s 80% buy share sits next to a crowd that ranges from X at 36% to News at 60%. No other tracker puts the two side by side.
10 analysts have weighed in: a Strong Buy consensus: 8 buy calls against 0 sell, with an average 12-month price target of $15.45.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is cooling and the 3 sources only partly agree, so the read is a Sell.
Analysts sit 35 points above the crowd average of 45%, the professionals are more constructive than retail. The split is inside the crowd: News reads 60% bullish while X sits at 36%, a 24-point spread that single-source trackers miss.
Over the 30-day window, Altimmune (ALT) buzz held subdued around 31.6 while the price drifted up 15.5% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 5.2M shares. Updated Jul 13, 2026. Over the last 7 trading days, ALT lost 3.2%. Buzz activity in the recent week averaged 34.2 and was relatively stable, swinging between 29.1 and 37.9. Recent volume is running below the 30-day average, pointing to quieter participation. Daily crowd sentiment leaned bullish on 10 of the 17 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Buzz, bullish share, the loudest item and the positive / neutral / negative split for every tracked source over the last 7 days.
No Polymarket data for this stock this week.
Query sentiment for ALT and 1000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live ALT sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Jul 13, 2026.
Based on aggregated sentiment from Reddit, X and News sources, Altimmune (ALT) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 45% bullish across 3 active sources. Those sources contribute 21 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Altimmune (ALT) is fairly quiet with 5 mentions across 13 tracked subreddits. The tone is 40% bullish with falling 3-day activity momentum, suggesting cooling attention.
Altimmune (ALT) sentiment is mixed across all 3 tracked sources. Reddit reads 40% bullish, News reads 60% bullish and x coverage is the most negative at 36% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
Social sentiment data shows consistently mixed discussion around Altimmune (ALT). All 3 tracked sources lean in different directions, with x being the most bearish at 36% bullish. 3-day activity momentum is falling across Reddit and X. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 11 mentions (52% of total volume). Reddit contributes 5 mentions and News contributes 5 mentions. Sentiment is mixed across all sources.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. ALT's sell signal at 93/100 conviction reflects consistently mixed sentiment across multiple platforms. It is a research shortcut, not financial advice.
The ALT sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
These stocks share a comparable sentiment profile to Altimmune with similar bullish ratios, signal direction and discussion volume. All 6 peers carry sell signals, pointing to broad bearish pressure rather than an ALT-specific issue.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key